DGX
$195.26+1.10 (+0.57%)
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
Recent News
How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks?
Quest Diagnostics has outpaced its healthcare peers over the past year, and analysts are maintaining a moderately positive outlook on its future performance.
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
DGX, DVA, OPCH and ADUS gain attention as telehealth, AI adoption and aging population drive growth in home healthcare services.
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 3.6% gain over the past six months, beating the S&P 500 by 2.3 percentage points.
Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains?
Elanco Animal Health (ELAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Softness
Event overview and recent stock performance Quest Diagnostics (DGX) has been drawing attention after recent share price moves, with the stock down 0.4% over the past day and 1.3% over the past week, while remaining positive over the past 3 months and over the past year. See our latest analysis for Quest Diagnostics. Short term share price weakness contrasts with firmer momentum over longer periods, with the recent 3 month share price return of 11.35% and 1 year total shareholder return of...